Literature DB >> 15011916

Open abdomen management of intra-abdominal sepsis.

Amy L Adkins1, James Robbins, Mario Villalba, Phillip Bendick, Charles J Shanley.   

Abstract

Despite surgical advances, antimicrobial therapy, and intensive care, the morbidity and mortality of intra-abdominal sepsis remains high. The primary purpose of this study was to determine whether open abdomen management of intra-abdominal sepsis reduces intensive care unit (ICU) and hospital mortality. The records of 81 consecutive patients with open abdomen management for intra-abdominal sepsis admitted to the surgical ICU from January 1998 to April 2002 were retrospectively reviewed. Outcomes were compared to a historical control group with primary abdominal closure, also admitted to the surgical ICU with intra-abdominal sepsis and matched for sex, age, source of sepsis, and APACHE III score. ICU mortality for the open abdomen group was 25 per cent versus 17 per cent for the control group. Hospital mortality was 33 per cent and 25 per cent for the open abdomen patients and historical controls, respectively. Both ICU and hospital length of stay were significantly longer for the open abdomen group. An overall fistula rate of 14.8 per cent was demonstrated in the open abdomen patients. A significant difference in overall ICU and hospital mortality was not demonstrated between patients treated with open abdomen management and historical controls. A prospective randomized study accounting for extent of sepsis may define a role for open abdomen management in selected subgroups of patients.

Entities:  

Mesh:

Year:  2004        PMID: 15011916

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  30 in total

Review 1.  Total management of the open abdomen.

Authors:  Demetrios Demetriades
Journal:  Int Wound J       Date:  2012-08       Impact factor: 3.315

2.  Novel method for delayed primary closure and incisional hernia prevention in open abdomen: COmbined and MOdified Definitive Abdominal wall closure (COMODA).

Authors:  R Villalobos Mori; Y Maestre González; Mª Mias Carballal; C Gas Ruiz; G Protti Ruiz; A Escartin Arias; J J Olsina Kissler
Journal:  Hernia       Date:  2019-04-09       Impact factor: 4.739

Review 3.  Management of peritonitis in the critically ill patient.

Authors:  Carlos A Ordoñez; Juan Carlos Puyana
Journal:  Surg Clin North Am       Date:  2006-12       Impact factor: 2.741

Review 4.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

5.  Open abdomen management after massive bowel resection for superior mesenteric arterial occlusion.

Authors:  Kenji Mimatsu; Takatsugu Oida; Hisao Kanou; Hiroshi Miyake; Sadao Amano
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

6.  Treatment of the open abdomen with the commercially available vacuum-assisted closure system in patients with abdominal sepsis: low primary closure rate.

Authors:  D Wondberg; H J Larusson; U Metzger; A Platz; U Zingg
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

7.  Enterocutaneous fistulas in the setting of trauma and critical illness.

Authors:  Joseph J Dubose; Jonathan B Lundy
Journal:  Clin Colon Rectal Surg       Date:  2010-09

8.  The impact of standardized protocol implementation for surgical damage control and temporary abdominal closure after emergent laparotomy.

Authors:  Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; Michael S Walters; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

9.  Pancreaticoatmospheric fistula following severe acute necrotising pancreatitis.

Authors:  Eve Simoneau; Talat Chughtai; Tarek Razek; Dan L Deckelbaum
Journal:  BMJ Case Rep       Date:  2014-12-17

10.  A focus on intra-abdominal infections.

Authors:  Massimo Sartelli
Journal:  World J Emerg Surg       Date:  2010-03-19       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.